Neurobiology: Cannabinoids act backwards

Nature

Volumn 410, Issue 6828, 2001, Pages

  Christie, MacDonald J ^a   Vaughan, Christopher W ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL;

AILMENTS;

DRUG DOSAGE;

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; CARRIER PROTEIN; DRONABINOL; FATTY ACID AMIDASE; GLUTAMIC ACID; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NEUROTRANSMITTER; PROTEIN AT; UNCLASSIFIED DRUG; DRUG RECEPTOR;

CENTRAL NERVOUS SYSTEM; DEPOLARIZATION; DRUG EFFECT; DRUG RESEARCH; GLAUCOMA; GLIA CELL; HIPPOCAMPUS; MIGRAINE; MULTIPLE SCLEROSIS; MUSCLE SPASM; NAUSEA; NEUROTRANSMISSION; PAIN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PYRAMIDAL NERVE CELL; SHORT SURVEY; SIGNAL TRANSDUCTION; SYNAPSE; VOMITING; ARTICLE; METABOLISM; NERVE CELL;

CANNABIS;

CANNABINOIDS; HIPPOCAMPUS; NEURONS; PYRAMIDAL CELLS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 0035967179     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35069167     Document Type: Article

References (7)

1. House of Lords Select Committee on Science and Technology Cannabis: The Scientific and Medical Evidence (The Stationery Office, London, 1998).
2. National Institutes of Health Report on the Medical Uses of Marijuana www.nih.gov/news/medmarijuana/MedicalMarijuana.htm(1997).
3. Piomelli, D., Giuffrida, A., Calignano, A. &Fonseca, R. Trends Pharmacol. Sci. 21, 218-224 (2000).
4. Wilson, R. I. &Nicoll, R. A. Nature 410, 588-592 (2001).
5. Ohno-Shosaku, T., Maejima, T. &Kano, M. Neuron 29, 729-738 (2001).
6. Kreitzer, A. C. &Regehr, W. G. Neuron 29, 717-727 (2001).
7. Pilter, T. A. &Alger, B. E. J. Neurosci. 12, 4122-4132 (1992).